The different effects of admission blood glucose levels on the outcomes of ST elevation myocardial infarction patients with and without diabetes

入院血糖水平对伴有和不伴有糖尿病的ST段抬高型心肌梗死患者预后的不同影响

阅读:1

Abstract

The effects of hyperglycemia on the prognosis of MI patients remain uncertain. This investigation evaluates the prognostic significance of hyperglycemia upon hospital admission in patients with ST-Elevation Myocardial Infarction and assesses how diabetes mellitus (DM) affects its prognostic relevance. This cross-sectional study examined data from 334 patients diagnosed with ST-segment elevation acute coronary syndrome, obtained from the Persian Cardiovascular Disease Registry. The study assessed hospital and one-year mortality as primary outcomes. Furthermore, cut-off points for blood glucose level on admission were determined and the predictive value of these cut-off values was analyzed using logistic regression analysis. In-hospital and one-year mortality rates were 22.1% and 26% for diabetic patients, and 20.2% and 24.1% for non-diabetic patients, with no substantial discrepancy between the groups (P = 0.607, P = 0.401). ROC curve analysis determined the admission blood glucose cut-off for predicting hospital mortality at 214 mg/dl in patients with diabetes (AUC = 0.66) and 148 mg/dl in patients without diabetes (AUC = 0.71). Blood glucose values was an independent factors related to in-hospital mortality, with odds ratios of 3.78 (95% CI 1.33-10.68, P = 0.012) for diabetics and 3.07 (95% CI 1.25-7.51, P = 0.014) for non-diabetics. Additionally, heightened admission glucose was correlated with greater mortality in one year in patients affected with MI irrespective of diabetes status. Blood glucose levels at admission independently predicted increased risk of mortality both during hospitalization and at one-year follow-up in patients with MI, with a notable effect on non-diabetic patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。